Dianthus Therapeutics Stock Analysis

Dianthus Stock Analysis Notes

About 91.0% of the company shares are held by institutions such as insurance companies. The book value of Dianthus Therapeutics was currently reported as 11.51. The company recorded earning per share (EPS) of 7.22. Dianthus Therapeutics had not issued any dividends in recent years. The entity had 1:16 split on the 12th of September 2023. To learn more about Dianthus Therapeutics call Marino MBA at 929 999 4055 or check out https://dianthustx.com.

Dianthus Therapeutics Investment Alerts

Dianthus Therapeutics Upcoming and Recent Events

Dianthus Largest EPS Surprises

View All Earnings Estimates

Dianthus Therapeutics Environmental, Social, and Governance (ESG) Scores

Dianthus Therapeutics Thematic Classifications

Dianthus Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 705.3 M.

Dianthus Profitablity

Management Efficiency

Dianthus Therapeutics has return on total asset (ROA) of (0.1896) % which means that it has lost $0.1896 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2599) %, meaning that it created substantial loss on money invested by shareholders. Dianthus Therapeutics' management efficiency ratios could be used to measure how well Dianthus Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.25. The current Return On Capital Employed is estimated to decrease to -0.3. As of now, Dianthus Therapeutics' Non Currrent Assets Other are increasing as compared to previous years. The Dianthus Therapeutics' current Other Assets is estimated to increase to about 146.1 K, while Total Assets are projected to decrease to under 112.5 M.

Technical Drivers

As of the 29th of November, Dianthus Therapeutics shows the Coefficient Of Variation of (1,863), standard deviation of 3.83, and Mean Deviation of 2.81. Dianthus Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Dianthus Therapeutics Price Movement Analysis

Dianthus Therapeutics Insider Trading Activities

Dianthus Therapeutics Predictive Daily Indicators

Dianthus Therapeutics Corporate Filings

Dianthus Therapeutics Forecast Models

Dianthus Therapeutics' time-series forecasting models are one of many Dianthus Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dianthus Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Dianthus Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Dianthus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Dianthus Therapeutics. By using and applying Dianthus Stock analysis, traders can create a robust methodology for identifying Dianthus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dianthus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dianthus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Dianthus Therapeutics stock analysis indicators help investors evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By understating and applying Dianthus Therapeutics stock analysis, traders can identify Dianthus Therapeutics position entry and exit signals to maximize returns.

When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.